Latest news
A Consortium Including Arctic Therapeutics Launches Synaptiq with Acquisition of Clinical-Stage SYN-001 Program
AKUREYRI, ICELAND AND PHILADELPHIA, PA – JULY 23, 2026 – A consortium of European and US-based investors and Nobias Therapeutics today announced the launch of Synaptiq Therapeutics, a privately held, clinical-stage biotechnology…
